Global Collaboration Launches Streamlined-Access to Shank3 cKO Research Model

Today, a new global collaboration between CureSHANK, Innoser, and Ozgene is streamlining access to a next-generation research tool: the Shank3 cKO mouse model. By combining genetic accuracy with simplified access, this new model aims to accelerate the development of new therapies for Phelan-McDermid syndrome (PMS).

Get the full story here.